Originalbeitrag in Fachzeitschrift
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFN gamma-driven immunopathology
Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F, et al. ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFN gamma-driven immunopathology. eLife. 2022;11. doi:https://doi.org/10.7554/eLife.74623
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Chris Oostenbrink
Univ.Prof. Dr. Chris Oostenbrink
Jan Walther Perthold
Dipl.-Ing. Jan Walther Perthold
Klemens Tümay Capraz
Dipl.-Ing. Klemens Tümay Capraz
